Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Advertisement

Phathom Pharmaceuticals (PHAT) Similar Stocks

Compare
537 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Phathom Pharmaceuticals
$15.00
$1.03B
60.09%
4 Buy
0 Hold
0 Sell
Strong Buy
Geron
$1.11
$721.34M
-70.71%
3 Buy
1 Hold
0 Sell
Strong Buy
Arbutus Biopharma
$4.48
$873.15M
22.35%
Urogen Pharma
$23.55
$1.11B
111.02%
5 Buy
0 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$4.15
$1.13B
95.75%
11 Buy
0 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$35.88
$1.93B
149.72%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAT
Phathom Pharmaceuticals
15.00
6.27
71.82%
GERN
Geron
1.11
-2.88
-72.18%
ABUS
Arbutus Biopharma
4.27
0.83
24.13%
URGN
Urogen Pharma
23.55
12.10
105.68%
TSHA
Taysha Gene Therapies
4.15
2.14
106.47%
ZBIO
Zenas BioPharma, Inc.
36.21
23.76
190.84%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis